Ethynodiol Diacetate
규격
297-76-7CAS 번호
206-044-9EC 번호
[(3S,8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetateIUPAC 명칭
C24H32O4화학식
384.5 g/mol분자량
ETHYNODIOL DIACETATE; 297-76-7; Femulen; Continuin; Etynodiol Acetate; Etynodiol diacetate; SC 11800; SC-11800; DTXSID4020614; 19-Nor-17alpha-pregn-4-en-20-yne-3beta,17-diol diacetate; CHEBI:31580; NSC-759288; (3-beta,17-alpha)-19-Norpregn-4-en-20-yne-3,17-diol diacetate; 17-alpha-Ethynyl-19-norandrost-4-ene-3-beta,17-beta-diol diacetate; 17alpha-Ethynyl-3,17-dihydroxy-4-estrene diacetate; 17alpha-Ethynylestr-4-ene-3beta,17beta-diol acetate; 3beta, 17beta-Diacetoxy-17alpha-ethynyl-4-oestrene; 17alpha-Ethynyl-4-estrene-3beta,17beta-diol diacetate; DTXCID00614; [(3S,8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate; 3beta,17beta-Diacetoxy-19-nor-17alpha-pregn-4-en-20-yne; 62H10A1236; 17alpha-Ethynyl-19-norandrost-4-ene-3beta,17-beta-diol diacetate; 19-norpregn-4-en-20-yn-3beta,17alpha-diol, diacetate; ZOVIA COMPONENT ETHYNODIOL DIACETATE; 19-Norpregn-4-en-20-yne-3,17-diol, diacetate, (3beta,17alpha)-; ((3S,8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta(a)phenanthren-3-yl) acetate; RefChem:596812; (3 beta, 17 alpha)-19-Norpregn-4-en-20-yne-3,17 diol Diacetate; 206-044-9; Ethyndiol Diacetate; Ethinodiol diacetate; Metrodiol; Luto-metrodiol; Cervicundin; Metrodiol diacetate; Ovulen 50; MFCD00083326; Ethynodiol (diacetate); Ethynodiol acetate; (3beta,17beta)-17-ethynylestr-4-ene-3,17-diyl diacetate; (3S,8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diyl diacetate; 19-Norpregn-4-en-20-yne-3,17-diol, diacetate, (3b,17a)-; NCGC00166138-01; Ethynodiol diacetate [USAN]; Etynodiol di(acetate); CCRIS 305; 8080 C. B.; Ethynodiol diacetate [Progestins]; EINECS 206-044-9; 17-alpha-Ethynyl-3,17-dihydroxy-4-estrene diacetate; 3-beta, 17-beta-Diacetoxy-17-alpha-ethynyl-4-oestrene; 17-alpha-Ethynylestr-4-ene-3-beta,17-beta-diol acetate; 17-alpha-Ethynyl-4-estrene-3-beta,17-beta-diol diacetate; 19-Norpregn-4-en-20-yne-3,17-diol, diacetate, (3.beta.,17.alpha.)-; Ethynodiol diacetate (JAN/USP); 3-beta,17-beta-Diacetoxy-19-nor-17-alpha-pregn-4-en-20-yne; Ethynodiol diacetate [USAN:USP]; UNII-62H10A1236; NCGC00186466-01; ethynodiol-diacetate; CAS-297-76-7; 19-Nor-17-alpha-pregn-4-en-20-yne-3-beta,17-diol diacetate; Prestwick0_000908; Prestwick1_000908; Prestwick2_000908; Prestwick3_000908; SCHEMBL40888; BSPBio_000756; MLS000028661; SPBio_002955; 17alpha-ethynylestr-4-ene-3beta,17beta-diyl diacetate; BPBio1_000832; GTPL7072; orb1225404; orb1310092; Ethynodiol diacetate (Standard); CHEMBL1200624; HY-B1089R; ETHYNODIOL DIACETATE [MI]; MSK1611; ETHYNODIOL DIACETATE [JAN]; HMS1570F18; HMS2097F18; HMS3714F18; ETYNODIOL DIACETATE [MART.]; HY-B1089; Tox21_112333; Tox21_112924; BDBM50237627; ETYNODIOL DIACETATE [WHO-DD]; LMST02030124; s3160; ETHYNODIOL DIACETATE [USP-RS]; AKOS015895252; Tox21_112333_1; CCG-220908; DB00823; NSC 759288; NCGC00166138-02; NCGC00166138-03; NCGC00166138-04; NCGC00166138-05; [(3S,8R,9S,10R,13S,14S,17R)-17-acetoxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate; AS-13382; ETHYNODIOL DIACETATE [ORANGE BOOK]; SMR000058858; SY111397; ETHYNODIOL DIACETATE [USP IMPURITY]; ETHYNODIOL DIACETATE [USP MONOGRAPH]; KELNOR COMPONENT ETHYNODIOL DIACETATE; OVULEN COMPONENT ETHYNODIOL DIACETATE; AB00513958; E1315; NS00028774; D01294; AB00513958_02; SR-01000872687; Q5405160; SR-01000872687-1; BRD-K46331928-001-05-8; BRD-K46331928-001-06-6; 3beta,17alpha-19-Norpregn-4-en-20-yne-3,17-diyl diacetate; Ethynodiol diacetate, United States Pharmacopeia (USP) Reference Standard동의어
